pharma market research - the original one-stop pharmaceutical information shop
PHARMA MARKET RESEARCH STUDIES
Global Pharmaceutical Biotech Market 2010-2025
World Smoking-Cessation Drug Market 2010-2025
Oncology Market Leaders – Analyses and Outlook – 2010-2025
Oncology Market Leaders – Analyses and Outlook – 2010-2025
World Ophthalmic Pharmaceutical Market 2010-2025
Anti-aging Products and Services: The Global Market
Healthcare Information Technology
2008/2009 Healthcare Research Review
06 January 2006
AHF Asks Medi-Cal to Place Restrictions on Glaxo AIDS Drug Trizivir
05 January 2006
Merck KGaA Names Engle New Generics Group Regional Director, North America
04 January 2006
Nutra Pharma Reports Discovery of New Gene Involved in Multiple Sclerosis
11 October 2005
GenPat77 Receives BMBF Grant to Accelerate Development of CEACAM1 Into
04 October 2005
PharmaMar's Sixth New Compound, PM02734, Enters Clinical Trials
Pharma Companies Spend 13% Less on Advertising in Europe
Urigen Opens IND for Phase IIb Clinical Trial with Interstitial Cystitis treatment
29 March 2005
Medicare Tobacco Cessation Follows Lead of Many Private Insurers
Theravance Announces Fast Track Designation for Investigational Antibiotic Telavancin
AMICAS Recruits Peter McClennen as President and Chief Operating Officer
Baxter Assumes Marketing and Distribution Rights for Cangene's WinRho SDF in the U.S.
Morphotek Announces Acceptance of Investigational New Drug Application for MORAb-003
Secretary Leavitt Names Additions to Senior Staff
Macular Degeneration venture for ParAllele and Iowa University
9 Out of 10 Doctors Have Legible Handwriting
Pilot Project Shows Promise for Type II Diabetics
21 March 2005
Genentech and Ipsen to Develop Sustained-Release Recombinant Human Growth Hormone
BAY 43-9006 Shown to Delay Disease Progression in Phase III Study in Advanced Kidney Cancer Patients
Ozgene Reached Milestone for Organon
New Findings on the Role of Inflammation in Allergic Disease at 2005 AAAAI Annual Meeting
Prostate Research Campaign UK Extends Funding Priority
Pharmaceutical Formulations, Inc. Announces the Resignation of its President and COO
Multiple Studies Demonstrate Efficacy and Safety of COPAXONE
Degarelix Shows Immediate Onset of Action and Sustained Activity in Men With Prostate Cancer
16 March 2005
Sigma-Aldrich Joins RNAi Consortium
ASB Launches ChIP-GLAS for the Detection of 20,000 Human Promoters From a Single Sample
Wyeth Responds to Patent Lawsuit Ruling
FDA Panel Recommends Licensure of sanofi pasteur's ADACEL Vaccine
Memory Pharmaceuticals Announces Departure of Dr. Axel Unterbeck
Huntleigh Healthcare L.L.C. Announces Contract With Novation
15 March 2005
FDA Rejects Public Citizen's Petition for AstraZeneca's CRESTOR
Medifast Appoints Michael S. McDevitt to Position of President
BioBusiness Alliance of Minnesota Announces Plans
WebMD Corporation Announces Acquisition of HealthShare Technology Inc.
Lantibio, Inc. Announces the Initiation of Clinical Trials in Dry Eye Syndrome
14 March 2005
MediciNova Initiates a Phase I Clinical Trial with MN-221
08 March 2005
Broadest-to-Date US Lung Cancer Study Compares Gender With Incidence and Survival
GlaxoSmithKline and Adolor Report Results from Phase 2 of Entereg(TM) (alvimopan)
First Derivation of Human Embryonic Stem Cells Without Exposure to Cell Feeders
Three New Studies Examine the Effect of ACTOS(R) (pioglitazone HCl)
Lifeblood: The Thrombosis Charity Backs Parliament's Push to 'Stop the Clots'
04 March 2005
Vicuron Updates on Novartis Peptide Deformylase Inhibitor Program
Alveolus Announces Implantation of First AERO(TM) Tracheobronchial Stent in the UK
Judge Throws Out Gov. Rollback on RN Staffing Ratio Law
BioGenex Files Second Patent Infringement Lawsuit Against Ventana Medical Systems
Itochu and Sosei Agree on Capital and Business Alliances
03 March 2005
Inherited Traits and Tumor Mutations Affect Response to Treatment
Brain Tumor With Dismal Prognosis in Infants Can Be Cured in Older Children
Human Pheromone Sciences, Inc. Conducting Human Studies on Naturally-Occurring Compound
PDI Announces Details of its 2005 Agreements with AstraZeneca
Cord Blood Registry Files Suit Against ViaCell and Viacord for Misleading Advertising
01 March 2005
Start of a Phase II Clinical Trial for Novel Anti-Anxiety Agent
Masimo Corp Announces Masimo Rainbow SET - First Pulse CO-Oximeter
Cardiac Science and Quinton Cardiology Systems Announce Signing of Definitive Merger Agreement
Researchers Find Mammography Comfort Aid Yields Better Detection and More Comfort
St. Paul Hospital First in Minnesota to Measure Brain Magnetic Fields
28 February 2005
Sosei Files Marketing Authorisation Application for SOT-375
YM BioSciences Reports Response Rate of 35.3% in Pediatric Glioma
Mylan and King Terminate Merger Agreement
Efficacy of Investigational Anti-HIV Agent Tipranavir Demonstrated by New Data
MerseyBIO Selects Autonomy to Support Biotechnology Network
GALENICA wins License and Distribution rights for ALOXI
Jayne Perkins, Easter Seals Tennessee's CEO, Retires
25 February 2005
PEGASYS Approved in the EU for the Treatment of Chronic Hepatitis B
Baseball Pitchers Can Increase Pitch Velocity by Strengthening Rotator Cuff
Surgical Treatment of Hip or Knee Arthritis Does Not Reduce Obesity
Total Knee Replacement: The Changing Patient Landscape and Advanced Procedures
Emerging Technologies in Spinal Surgery
23 February 2005
Millennium Announces Findings from Novel Antibody-Chemotherapeutic
WORLDWIDE DNA SEQUENCING AND PROTEOMICS MARKETS
RNs Denounce Gov. for Harassment of Nurse Critics
Sosei In-License Urology Drug From Otsuka
FDA provides LMS clearance for new core product
WHO Framework Convention on Tobacco Control Enters into Force
Transgene: MVA-Muc1-IL2 Meets Primary Endpoint in Lung Cancer Phase II
16 February 2005
Immtech Appoints Daniel Schmitt Vice President, Licensing and Commercial Development
Stereotaxis Appoints Abhi Acharya and David W. Benfer to Board of Directors
URAC Releases Clinical Accreditation Standards for Public Comment
Astralis Ltd. Appoints Mr. James Sharpe as CEO
World's First Successful Hand Transplant Recipient Receives Six-Year Check Up
Tyco CFO David FitzPatrick to Retire at End of 2005
Freeths Puts Positive Spin On Critical Pharmaceuticals
15 February 2005
Transgene Appoints Jean-Yves Bonnefoy as New Chief Scientific Officer
CardioSoft Developing New Ischemia Detection Algorithms
4SC and Sanwa Kagaku Kenkyusho Enter Into Multi-Year Drug Discovery Collaboration
American Red Cross Issues Urgent Appeal For Blood Donations
Hill-Rom Adds New Wireless Device Interface to its Portfolio of Real-Time Products
Sigma-Aldrich Introduces the TargeTron(TM) Gene Knockout System
Moll Industries Increases Worldwide Production
11 February 2005
Bostwick Laboratories, Inc. Opens First International Location
Ambrisentan PAH Long-Term Safety and Efficacy Data to Be Presented
Technology Solutions Company Guides QuadraMed Implementation to Automate Sarbanes-Oxley Compliance
New Meningococcal Disease Vaccination Recommendations Expected To Reduce Disability
Isotechnika Achieves Target Enrolment for Phase III Psoriasis Trial
Valium Inventor Inducted into National Inventors Hall of Fame
10 February 2005
Shire Announces Suspension of ADDERALL XR(R) Sales in Canada
Doe Run Peru Reports Drop in Emissions, Blood Lead Levels
Spector, Roseman & Kodroff, P.C. Files Class Action Suit Against EPIX Pharmaceuticals
Clinical Data From Initial REVLIMID(TM) Study in Myelodysplastic Syndromes Reported
LeMaitre Vascular Acquires Endomed
Temperature Data Systems is Now Sensitech Inc.
09 February 2005
Positive Phase I/II Results from Pancreatic Cancer Study Announced
Cleveland Clinic Awarded $17.22 Million Federal Grant to Advance Understanding of Heart Attacks
Repligen and GE Healthcare Expand Protein A Supply Agreement
The Risk of Both Stroke CHD Nearly Doubles With Elevated Lp-PLA2 Activity
Alfacell Corporation Expands ONCONASE(R) Clinical Program
Forest Laboratories, Inc. Announces Launch of Clinical Trial Registry
08 February 2005
EBI Introduces the New Pro Osteon(R) Line of Osteobiologics
Alveolus Enters Into UK Distribution Agreement
Former Heinz North America CEO Joins Atkins Nutritionals
Haemonetics and ZLB Plasma Services Sign Exclusive Supply Contract
African-Americans May Need More Medication to Control Asthma
Neurocrine Biosciences Announces Resubmission Status of Indiplon
BioCryst Pharmaceuticals Strengthens Management Team With New Vice President
07 February 2005
CooperVision Announces Management Changes Following Ocular Sciences Acquisition
Biotechnology Council of New Jersey Annual Meeting Message One of Promise for NJ Industry
The Beryl Companies Acquire Call Center Service Agreements
Atugen and ASINEX Announce Discovery Program for Novel Protein Kinase Target
India Begins Its First Preventive AIDS Vaccine Trial
Gish Cardiopulmonary Bypass Equipment Used in Transfusion-free Surgery
Second CT Laser Mammography System Sold in Italy
Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation
U.S. FDA Grants Full Approval to DOXIL(R) Following Submission of Phase III Data
Ozone Friendly Formulation, Flovent(R) HFA Inhalation Aerosol, Now Available
Viragen Appoints Dartmouth Cancer Research Scientist to Board of Directors
Circles of DNA from Immune Cell Gene Shuffling to Predict Stem Cell Transplantation?
Best Mfg. and SHOWA Company Strike Exclusive Agreement
Abbott Enters Into Agreement With Cleveland Clinic for Myeloperoxidase (MPO) Cardiac Test
26 January 2005
Chiltern launches global EDC Solutions
14 October 2004
Chiltern project leader addresses eminent scientific audience on Malaria
13 October 2004
AMID FLU VACCINE SHORTAGES AND CONCERNS ABOUT FLU PANDEMIC,
22 September 2004
HARROW PRIMARY CARE TRUST INVESTS IN MAPINFO HEALTHPRO
08 September 2004
REVOLUTIONARY PAGER-SIZE MONITOR MEASURES MORE THAN 50 PARAMETERS
03 September 2004
Xceleron assist GSK in commissioning Pharma’s first Accelerator Mass Spectrometer
01 September 2004
ASTRAZENECA SUBMITS APPLICATIONS FOR NEXIUM® FOR HEALING OF NSAID-ASSOCIATED ULCERS
12 April 2004
Increasing incidence of HIV/HBV co-infection providesopportunities to fill the gap in HIV market
02 December 2003
The Tried & the True & the New: A Comprehensive Report on Molecular Diagnostics Markets
01 December 2003
NEARLY EIGHTY PERCENT OF VIAGRA® USERS PREFERRED NOT TO SWITCH
GlaxoSmithKline Reinforces its Committment to the Orange Card
Wyeth shareholder Rights Plan Terminated Early
POSITIVE OPINION GIVEN ON APPROVABILITY OF FASLODEX™ IN EU
NEW DATA SHOW U.S. BREASTFEEDING RATES AT ALL-TIME RECORDED HIGH
Wyeth Prevails in Diet Drug Case
keithw@cmsinfo.com
CMSInfo (Chiltern Magazine Services Ltd.) is a company registered at Companies House in England and Wales (Company No. 3240740).Data Protection Act 1998 (registration number R0094104).Terms and Conditions
Copyright CMSinfo.com© 1995-2008 keithw@cmsinfo.com
06 January 2006
AHF Asks Medi-Cal to Place Restrictions on Glaxo AIDS Drug Trizivir
05 January 2006
Merck KGaA Names Engle New Generics Group Regional Director, North America
04 January 2006
Nutra Pharma Reports Discovery of New Gene Involved in Multiple Sclerosis
11 October 2005
GenPat77 Receives BMBF Grant to Accelerate Development of CEACAM1 Into
04 October 2005
PharmaMar's Sixth New Compound, PM02734, Enters Clinical Trials
Pharma Companies Spend 13% Less on Advertising in Europe
Urigen Opens IND for Phase IIb Clinical Trial with Interstitial Cystitis treatment
29 March 2005
Medicare Tobacco Cessation Follows Lead of Many Private Insurers
Theravance Announces Fast Track Designation for Investigational Antibiotic Telavancin
AMICAS Recruits Peter McClennen as President and Chief Operating Officer
Baxter Assumes Marketing and Distribution Rights for Cangene's WinRho SDF in the U.S.
Morphotek Announces Acceptance of Investigational New Drug Application for MORAb-003
Secretary Leavitt Names Additions to Senior Staff
Macular Degeneration venture for ParAllele and Iowa University
9 Out of 10 Doctors Have Legible Handwriting
Pilot Project Shows Promise for Type II Diabetics
21 March 2005
Genentech and Ipsen to Develop Sustained-Release Recombinant Human Growth Hormone
BAY 43-9006 Shown to Delay Disease Progression in Phase III Study in Advanced Kidney Cancer Patients
Ozgene Reached Milestone for Organon
New Findings on the Role of Inflammation in Allergic Disease at 2005 AAAAI Annual Meeting
Prostate Research Campaign UK Extends Funding Priority
Pharmaceutical Formulations, Inc. Announces the Resignation of its President and COO
Multiple Studies Demonstrate Efficacy and Safety of COPAXONE
Degarelix Shows Immediate Onset of Action and Sustained Activity in Men With Prostate Cancer
16 March 2005
Sigma-Aldrich Joins RNAi Consortium
ASB Launches ChIP-GLAS for the Detection of 20,000 Human Promoters From a Single Sample
Wyeth Responds to Patent Lawsuit Ruling
FDA Panel Recommends Licensure of sanofi pasteur's ADACEL Vaccine
Memory Pharmaceuticals Announces Departure of Dr. Axel Unterbeck
Huntleigh Healthcare L.L.C. Announces Contract With Novation
15 March 2005
FDA Rejects Public Citizen's Petition for AstraZeneca's CRESTOR
Medifast Appoints Michael S. McDevitt to Position of President
BioBusiness Alliance of Minnesota Announces Plans
WebMD Corporation Announces Acquisition of HealthShare Technology Inc.
Lantibio, Inc. Announces the Initiation of Clinical Trials in Dry Eye Syndrome
14 March 2005
MediciNova Initiates a Phase I Clinical Trial with MN-221
08 March 2005
Broadest-to-Date US Lung Cancer Study Compares Gender With Incidence and Survival
GlaxoSmithKline and Adolor Report Results from Phase 2 of Entereg(TM) (alvimopan)
First Derivation of Human Embryonic Stem Cells Without Exposure to Cell Feeders
Three New Studies Examine the Effect of ACTOS(R) (pioglitazone HCl)
Lifeblood: The Thrombosis Charity Backs Parliament's Push to 'Stop the Clots'
04 March 2005
Vicuron Updates on Novartis Peptide Deformylase Inhibitor Program
Alveolus Announces Implantation of First AERO(TM) Tracheobronchial Stent in the UK
Judge Throws Out Gov. Rollback on RN Staffing Ratio Law
BioGenex Files Second Patent Infringement Lawsuit Against Ventana Medical Systems
Itochu and Sosei Agree on Capital and Business Alliances
03 March 2005
Inherited Traits and Tumor Mutations Affect Response to Treatment
Brain Tumor With Dismal Prognosis in Infants Can Be Cured in Older Children
Human Pheromone Sciences, Inc. Conducting Human Studies on Naturally-Occurring Compound
PDI Announces Details of its 2005 Agreements with AstraZeneca
Cord Blood Registry Files Suit Against ViaCell and Viacord for Misleading Advertising
01 March 2005
Start of a Phase II Clinical Trial for Novel Anti-Anxiety Agent
Masimo Corp Announces Masimo Rainbow SET - First Pulse CO-Oximeter
Cardiac Science and Quinton Cardiology Systems Announce Signing of Definitive Merger Agreement
Researchers Find Mammography Comfort Aid Yields Better Detection and More Comfort
St. Paul Hospital First in Minnesota to Measure Brain Magnetic Fields
28 February 2005
Sosei Files Marketing Authorisation Application for SOT-375
YM BioSciences Reports Response Rate of 35.3% in Pediatric Glioma
Mylan and King Terminate Merger Agreement
Efficacy of Investigational Anti-HIV Agent Tipranavir Demonstrated by New Data
MerseyBIO Selects Autonomy to Support Biotechnology Network
GALENICA wins License and Distribution rights for ALOXI
Jayne Perkins, Easter Seals Tennessee's CEO, Retires
25 February 2005
PEGASYS Approved in the EU for the Treatment of Chronic Hepatitis B
Baseball Pitchers Can Increase Pitch Velocity by Strengthening Rotator Cuff
Surgical Treatment of Hip or Knee Arthritis Does Not Reduce Obesity
Total Knee Replacement: The Changing Patient Landscape and Advanced Procedures
Emerging Technologies in Spinal Surgery
23 February 2005
Millennium Announces Findings from Novel Antibody-Chemotherapeutic
WORLDWIDE DNA SEQUENCING AND PROTEOMICS MARKETS
RNs Denounce Gov. for Harassment of Nurse Critics
Sosei In-License Urology Drug From Otsuka
FDA provides LMS clearance for new core product
WHO Framework Convention on Tobacco Control Enters into Force
Transgene: MVA-Muc1-IL2 Meets Primary Endpoint in Lung Cancer Phase II
16 February 2005
Immtech Appoints Daniel Schmitt Vice President, Licensing and Commercial Development
Stereotaxis Appoints Abhi Acharya and David W. Benfer to Board of Directors
URAC Releases Clinical Accreditation Standards for Public Comment
Astralis Ltd. Appoints Mr. James Sharpe as CEO
World's First Successful Hand Transplant Recipient Receives Six-Year Check Up
Tyco CFO David FitzPatrick to Retire at End of 2005
Freeths Puts Positive Spin On Critical Pharmaceuticals
15 February 2005
Transgene Appoints Jean-Yves Bonnefoy as New Chief Scientific Officer
CardioSoft Developing New Ischemia Detection Algorithms
4SC and Sanwa Kagaku Kenkyusho Enter Into Multi-Year Drug Discovery Collaboration
American Red Cross Issues Urgent Appeal For Blood Donations
Hill-Rom Adds New Wireless Device Interface to its Portfolio of Real-Time Products
Sigma-Aldrich Introduces the TargeTron(TM) Gene Knockout System
Moll Industries Increases Worldwide Production
11 February 2005
Bostwick Laboratories, Inc. Opens First International Location
Ambrisentan PAH Long-Term Safety and Efficacy Data to Be Presented
Technology Solutions Company Guides QuadraMed Implementation to Automate Sarbanes-Oxley Compliance
New Meningococcal Disease Vaccination Recommendations Expected To Reduce Disability
Isotechnika Achieves Target Enrolment for Phase III Psoriasis Trial
Valium Inventor Inducted into National Inventors Hall of Fame
10 February 2005
Shire Announces Suspension of ADDERALL XR(R) Sales in Canada
Doe Run Peru Reports Drop in Emissions, Blood Lead Levels
Spector, Roseman & Kodroff, P.C. Files Class Action Suit Against EPIX Pharmaceuticals
Clinical Data From Initial REVLIMID(TM) Study in Myelodysplastic Syndromes Reported
LeMaitre Vascular Acquires Endomed
Temperature Data Systems is Now Sensitech Inc.
09 February 2005
Positive Phase I/II Results from Pancreatic Cancer Study Announced
Cleveland Clinic Awarded $17.22 Million Federal Grant to Advance Understanding of Heart Attacks
Repligen and GE Healthcare Expand Protein A Supply Agreement
The Risk of Both Stroke CHD Nearly Doubles With Elevated Lp-PLA2 Activity
Alfacell Corporation Expands ONCONASE(R) Clinical Program
Forest Laboratories, Inc. Announces Launch of Clinical Trial Registry
08 February 2005
EBI Introduces the New Pro Osteon(R) Line of Osteobiologics
Alveolus Enters Into UK Distribution Agreement
Former Heinz North America CEO Joins Atkins Nutritionals
Haemonetics and ZLB Plasma Services Sign Exclusive Supply Contract
African-Americans May Need More Medication to Control Asthma
Neurocrine Biosciences Announces Resubmission Status of Indiplon
BioCryst Pharmaceuticals Strengthens Management Team With New Vice President
07 February 2005
CooperVision Announces Management Changes Following Ocular Sciences Acquisition
Biotechnology Council of New Jersey Annual Meeting Message One of Promise for NJ Industry
The Beryl Companies Acquire Call Center Service Agreements
Atugen and ASINEX Announce Discovery Program for Novel Protein Kinase Target
India Begins Its First Preventive AIDS Vaccine Trial
Gish Cardiopulmonary Bypass Equipment Used in Transfusion-free Surgery
Second CT Laser Mammography System Sold in Italy
Schering-Plough to Webcast CFO Robert J. Bertolini's Presentation
U.S. FDA Grants Full Approval to DOXIL(R) Following Submission of Phase III Data
Ozone Friendly Formulation, Flovent(R) HFA Inhalation Aerosol, Now Available
Viragen Appoints Dartmouth Cancer Research Scientist to Board of Directors
Circles of DNA from Immune Cell Gene Shuffling to Predict Stem Cell Transplantation?
Best Mfg. and SHOWA Company Strike Exclusive Agreement
Abbott Enters Into Agreement With Cleveland Clinic for Myeloperoxidase (MPO) Cardiac Test
26 January 2005
Chiltern launches global EDC Solutions
14 October 2004
Chiltern project leader addresses eminent scientific audience on Malaria
13 October 2004
AMID FLU VACCINE SHORTAGES AND CONCERNS ABOUT FLU PANDEMIC,
22 September 2004
HARROW PRIMARY CARE TRUST INVESTS IN MAPINFO HEALTHPRO
08 September 2004
REVOLUTIONARY PAGER-SIZE MONITOR MEASURES MORE THAN 50 PARAMETERS
03 September 2004
Xceleron assist GSK in commissioning Pharma’s first Accelerator Mass Spectrometer
01 September 2004
ASTRAZENECA SUBMITS APPLICATIONS FOR NEXIUM® FOR HEALING OF NSAID-ASSOCIATED ULCERS
12 April 2004
Increasing incidence of HIV/HBV co-infection providesopportunities to fill the gap in HIV market
02 December 2003
The Tried & the True & the New: A Comprehensive Report on Molecular Diagnostics Markets
01 December 2003
NEARLY EIGHTY PERCENT OF VIAGRA® USERS PREFERRED NOT TO SWITCH
GlaxoSmithKline Reinforces its Committment to the Orange Card
Wyeth shareholder Rights Plan Terminated Early
POSITIVE OPINION GIVEN ON APPROVABILITY OF FASLODEX™ IN EU
NEW DATA SHOW U.S. BREASTFEEDING RATES AT ALL-TIME RECORDED HIGH
Wyeth Prevails in Diet Drug Case
